TrialDiabetes, obesity & metabolism2022

Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial.

João Pedro Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.